Shenzhen - Delayed Quote CNY

Chongqing Zhifei Biological Products Co., Ltd. (300122.SZ)

34.39 +0.18 (+0.53%)
As of 11:57 AM GMT+8. Market Open.
Loading Chart for 300122.SZ
DELL
  • Previous Close 34.21
  • Open 41.18
  • Bid 34.39 x --
  • Ask 34.41 x --
  • Day's Range 33.81 - 34.55
  • 52 Week Range 33.51 - 70.27
  • Volume 15,183,944
  • Avg. Volume 20,064,889
  • Market Cap (intraday) 82.322B
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) 11.02
  • EPS (TTM) 3.12
  • Earnings Date --
  • Forward Dividend & Yield 0.50 (1.46%)
  • Ex-Dividend Date Jun 16, 2023
  • 1y Target Est 56.90

Chongqing Zhifei Biological Products Co., Ltd. engages in the research, development, manufacture, marketing, distribution, import, and export of vaccines and biological products in China. It also provides cold storage services. The company was founded in 2002 and is based in Chongqing, China.

www.zhifeishengwu.com

6,545

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 300122.SZ

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

300122.SZ
43.72%
SSE Composite Index
3.43%

1-Year Return

300122.SZ
33.30%
SSE Composite Index
5.76%

3-Year Return

300122.SZ
72.06%
SSE Composite Index
11.43%

5-Year Return

300122.SZ
23.34%
SSE Composite Index
1.50%

Compare To: 300122.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300122.SZ

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    81.89B

  • Enterprise Value

    83.96B

  • Trailing P/E

    10.95

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.54

  • Price/Book (mrq)

    2.51

  • Enterprise Value/Revenue

    1.58

  • Enterprise Value/EBITDA

    9.58

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.10%

  • Return on Assets (ttm)

    10.97%

  • Return on Equity (ttm)

    25.44%

  • Revenue (ttm)

    53.14B

  • Net Income Avi to Common (ttm)

    7.5B

  • Diluted EPS (ttm)

    3.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.97B

  • Total Debt/Equity (mrq)

    15.42%

  • Levered Free Cash Flow (ttm)

    -1.64B

Research Analysis: 300122.SZ

Analyst Price Targets

38.10
56.90 Average
34.39 Current
78.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: 300122.SZ

People Also Watch